BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 21653804)

  • 1. Agreement between prostate cancer patients and their clinicians about utilities and attribute importance.
    Elstein AS; Chapman GB; Chmiel JS; Knight SJ; Chan C; Nadler RB; Kuzel TM; Siston AK; Bennett CL
    Health Expect; 2004 Jun; 7(2):115-25. PubMed ID: 15117386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life in home-dwelling cancer patients aged 80 years and older: a systematic review.
    Hjelmeland IHH; Drageset J; Nordvik Ø; Beisland EG
    Health Qual Life Outcomes; 2022 Nov; 20(1):154. PubMed ID: 36443850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Patient-Centered Utility Index for Non-Small Cell Lung Cancer in the United States.
    Swan JS; Lennes IT; Stump NN; Temel JS; Wang D; Keller L; Donelan K
    MDM Policy Pract; 2018; 3(2):2381468318801565. PubMed ID: 30349874
    [No Abstract]   [Full Text] [Related]  

  • 4. The Role of Condition-Specific Preference-Based Measures in Health Technology Assessment.
    Rowen D; Brazier J; Ara R; Azzabi Zouraq I
    Pharmacoeconomics; 2017 Dec; 35(Suppl 1):33-41. PubMed ID: 29052164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catalog and comparison of societal preferences (utilities) for lung cancer health states: results from the Cancer Care Outcomes Research and Surveillance (CanCORS) study.
    Tramontano AC; Schrag DL; Malin JK; Miller MC; Weeks JC; Swan JS; McMahon PM
    Med Decis Making; 2015 Apr; 35(3):371-87. PubMed ID: 25670839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing quality of life in patients with prostate cancer: a systematic and standardized comparison of available instruments.
    Schmidt S; Garin O; Pardo Y; Valderas JM; Alonso J; Rebollo P; Rajmil L; Garcia-Forero C; Ferrer M;
    Qual Life Res; 2014 Oct; 23(8):2169-81. PubMed ID: 24748557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conceptualizing global health-related quality of life in bladder cancer.
    Perlis N; Krahn M; Alibhai S; Finelli A; Ritvo P; Bremner KE; Kulkarni G
    Qual Life Res; 2014 Oct; 23(8):2153-67. PubMed ID: 24729055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient and societal value functions for the testing morbidities index.
    Swan JS; Kong CY; Lee JM; Itauma O; Halpern EF; Lee PA; Vavinskiy S; Williams O; Zoltick ES; Donelan K
    Med Decis Making; 2013 Aug; 33(6):819-38. PubMed ID: 23689044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A reference set of health utilities for long-term survivors of prostate cancer: population-based data from Ontario, Canada.
    Krahn MD; Bremner KE; Alibhai SM; Ni A; Tomlinson G; Laporte A; Naglie G
    Qual Life Res; 2013 Dec; 22(10):2951-62. PubMed ID: 23564620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptation and validation of the Spanish version of the Patient-Oriented Prostate Utility Scale (PORPUS).
    Avila M; Pardo Y; Castells M; Ferrer F; Boladeras A; Pera J; Prada PJ; Guix B; de Paula B; Hernandez H; Pont A; Alonso J; Garin O; Bremner K; Krahn M; Ferrer M;
    Qual Life Res; 2014 Nov; 23(9):2481-7. PubMed ID: 24789667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health utility bias: a systematic review and meta-analytic evaluation.
    Doctor JN; Bleichrodt H; Lin HJ
    Med Decis Making; 2010; 30(1):58-67. PubMed ID: 18556637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review and meta-analysis of prostate cancer utilities.
    Bremner KE; Chong CA; Tomlinson G; Alibhai SM; Krahn MD
    Med Decis Making; 2007; 27(3):288-98. PubMed ID: 17502448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a utility weighting function for the patient-oriented prostate utility scale (PORPUS).
    Tomlinson G; Bremner KE; Ritvo P; Naglie G; Krahn MD
    Med Decis Making; 2012; 32(1):11-30. PubMed ID: 21653804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting utility scores for prostate cancer: mapping the Prostate Cancer Index to the Patient-Oriented Prostate Utility Scale (PORPUS).
    Bremner KE; Mitsakakis N; Wilson L; Krahn MD
    Prostate Cancer Prostatic Dis; 2014 Mar; 17(1):47-56. PubMed ID: 24126796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient and community preferences for outcomes in prostate cancer: implications for clinical policy.
    Krahn M; Ritvo P; Irvine J; Tomlinson G; Bremner KE; Bezjak A; Trachtenberg J; Naglie G
    Med Care; 2003 Jan; 41(1):153-64. PubMed ID: 12544552
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.